Xtant Medical Reports First Quarter 2025 Financial Results

Revenue Increases 18% Year-over-YearDelivers Positive Net Income and $1.3 Million in Operating Cash FlowIncreases 2025 Revenue Guidance to$127 Million to $131 Million BELGRADE, Mont., May 12, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and wound care disorders, today reported financial and operating results for the first quarter ended March 31, 2025.First Quarter 2025 Fina ...